These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 12845616)

  • 1. Tenascins: regulation and putative functions during pathological stress.
    Chiquet-Ehrismann R; Chiquet M
    J Pathol; 2003 Jul; 200(4):488-99. PubMed ID: 12845616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascins and their implications in diseases and tissue mechanics.
    Brellier F; Tucker RP; Chiquet-Ehrismann R
    Scand J Med Sci Sports; 2009 Aug; 19(4):511-9. PubMed ID: 19422658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome.
    Burch GH; Gong Y; Liu W; Dettman RW; Curry CJ; Smith L; Miller WL; Bristow J
    Nat Genet; 1997 Sep; 17(1):104-8. PubMed ID: 9288108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.
    Schalkwijk J; Zweers MC; Steijlen PM; Dean WB; Taylor G; van Vlijmen IM; van Haren B; Miller WL; Bristow J
    N Engl J Med; 2001 Oct; 345(16):1167-75. PubMed ID: 11642233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenascins and the importance of adhesion modulation.
    Chiquet-Ehrismann R; Tucker RP
    Cold Spring Harb Perspect Biol; 2011 May; 3(5):. PubMed ID: 21441591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenascins.
    Chiquet-Ehrismann R
    Int J Biochem Cell Biol; 2004 Jun; 36(6):986-90. PubMed ID: 15094113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin-X deficiency in autosomal recessive Ehlers-Danlos syndrome.
    Lindor NM; Bristow J
    Am J Med Genet A; 2005 May; 135(1):75-80. PubMed ID: 15793839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β (TGF-β) pathway abnormalities in tenascin-X deficiency associated with CAH-X syndrome.
    Morissette R; Merke DP; McDonnell NB
    Eur J Med Genet; 2014 Feb; 57(2-3):95-102. PubMed ID: 24380766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins.
    Halper J; Kjaer M
    Adv Exp Med Biol; 2014; 802():31-47. PubMed ID: 24443019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition.
    Egging D; van Vlijmen-Willems I; van Tongeren T; Schalkwijk J; Peeters A
    Connect Tissue Res; 2007; 48(2):93-8. PubMed ID: 17453911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complexity in regulating the expression of tenascins.
    Chiquet-Ehrismann R; Hagios C; Schenk S
    Bioessays; 1995 Oct; 17(10):873-8. PubMed ID: 7487968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition.
    Mao JR; Taylor G; Dean WB; Wagner DR; Afzal V; Lotz JC; Rubin EM; Bristow J
    Nat Genet; 2002 Apr; 30(4):421-5. PubMed ID: 11925569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin-X deficiency and Ehlers-Danlos syndrome: a case report and review of the literature.
    O'Connell M; Burrows NP; van Vlijmen-Willems MJ; Clark SM; Schalkwijk J
    Br J Dermatol; 2010 Dec; 163(6):1340-5. PubMed ID: 20649799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle characteristics and altered myofascial force transmission in tenascin-X-deficient mice, a mouse model of Ehlers-Danlos syndrome.
    Huijing PA; Voermans NC; Baan GC; Busé TE; van Engelen BG; de Haan A
    J Appl Physiol (1985); 2010 Oct; 109(4):986-95. PubMed ID: 20576846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases.
    Matsumoto KI; Aoki H
    Front Immunol; 2020; 11():609752. PubMed ID: 33335533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adhesion modulating properties of tenascin-W.
    Brellier F; Martina E; Chiquet M; Ferralli J; van der Heyden M; Orend G; Schittny JC; Chiquet-Ehrismann R; Tucker RP
    Int J Biol Sci; 2012; 8(2):187-94. PubMed ID: 22211116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between cell and extracellular matrix in heart disease: multiple roles of tenascin-C in tissue remodeling.
    Imanaka-Yoshida K; Hiroe M; Yoshida T
    Histol Histopathol; 2004 Apr; 19(2):517-25. PubMed ID: 15024713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissues: signalling by tenascins.
    Chiquet-Ehrismann R; Tucker RP
    Int J Biochem Cell Biol; 2004 Jun; 36(6):1085-9. PubMed ID: 15094123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical and cardiovascular survey of Ehlers-Danlos syndrome patients with complete deficiency of tenascin-X.
    Peeters AC; Kucharekova M; Timmermans J; van den Berkmortel FW; Boers GH; Nováková IR; Egging D; den Heijer M; Schalkwijk J
    Neth J Med; 2004 May; 62(5):160-2. PubMed ID: 15366699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of human tenascin-X domains with dermal extracellular matrix molecules.
    Egging D; van den Berkmortel F; Taylor G; Bristow J; Schalkwijk J
    Arch Dermatol Res; 2007 Jan; 298(8):389-96. PubMed ID: 17033827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.